1-3 of 3
Lasse Hjort Jakobsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

Joachim Baech, Marianne Tang Severinsen, Andreas K. Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian B. Poulsen, Peter Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström Smedby, Sandra Eloranta, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4427–4435.
https://doi.org/10.1182/bloodadvances.2021006859
Published: 2022
Includes: Supplemental data
Journal Articles

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study

Joel Joelsson, Tove Wästerlid, Richard Rosenquist, Lasse Hjort Jakobsen, Tarec C. El-Galaly, Karin E. Smedby, Sandra Eloranta
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2657–2666.
https://doi.org/10.1182/bloodadvances.2021006369
Published: 2022
Includes: Supplemental data
Journal Articles

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment

Clinical Trials & Observations
Paw Jensen, Lasse Hjort Jakobsen, Martin Bøgsted, Joachim Baech, Simon Lykkeboe, Marianne Tang Severinsen, Peter Vestergaard, Tarec Christoffer El-Galaly
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2549–2556.
https://doi.org/10.1182/bloodadvances.2021006330
Published: 2022
Includes: Supplemental data